Archives for February 2014

February 2014 - Page 9 of 20 - Money Morning - Only the News You Can Profit From

General Motors (NYSE: GM) Recall Is a "Legacy Issue for Years to Come"

Thursday's General Motors Company (NYSE: GM) recall of nearly 800,000 compact cars in North America is markedly different from the slough of other 2014 recalls from the likes of Toyota Motor Corp. (NYSE: TM), Ford Motor Corp. (NYSE: F), and Tesla Motors Inc. (Nasdaq: TSLA).

That's because, according to depositions in a civil lawsuit against GM, the carmaker knew about the defect that's caused fatal and nonfatal crashes since at least 2004.

Read More…

Chelsea Therapeutics International (Nasdaq: CHTP) Stock Climbs 35% on Huge FDA Win

Good news for micro-cap Chelsea Therapeutics International Ltd. (Nasdaq: CHTP) – and its investors. The company's drug to treat a rare type of low blood pressure has received accelerated U.S. Food and Drug Administration approval.

The welcome news came Monday after the close. Nearly 14 million shares changed hands during Monday's regular trading session as investors awaited approval news.

Shares of the Charlotte, N.C.-based company were halted after-hours as the decision loomed. When the stock resumed trading, shares surged 37%, or $1.87, to $6.79.

To continue reading, please click here...

Tesla Motors (Nasdaq: TSLA) Stock Soars on Earnings Beat

Tesla Motors Inc. (Nasdaq: TSLA) stock reached another all-time high yesterday (Tuesday) of $205.72 ahead of today's earnings report. TSLA stock has gained 516% since the beginning of 2013 and had set a previous high of $202.20 just one week ago.

Analysts expect earnings per share (EPS) of $0.19 for Tesla, on revenue of $663 million for Q4. That revenue estimate is a 116% increase from the same quarter last year.

For the full year 2013, analysts project EPS of $0.63 on $2.39 billion in revenue.

Unlike many companies who report earnings, Tesla's profit will not be the main highlight.

This is what 2014 holds for Tesla...

Convert These Costs into Profits

It's fair to say that adding up your health, auto, homeowner's, life, and business insurance costs (to name just a few) can lead to a massive tab. And it puts a huge dent in your available investment capital.

But it doesn't have to.

Let's take a look at our insurance costs compared to some other countries, their drivers, and… most importantly, how to knock them down and profit from what we save.

how to knock them down and profit from what we save.

Winners and Losers in the Stock Market Today

Stock market today, Feb. 18:U.S. stocks kicked off a shortened trading week predominantly in positive territory, with the Nasdaq making strides even as home builder confidence fell and manufacturing declined more than expected.

[rwc_chart_single name="DJIA"]

The Nasdaq closed up 0.68% at 4,273; the S&P 500 Index closed up 0.13% at 1,841 and the Dow Jones Industrial Average closed down 0.15% at 16,130.

To continue reading, please click here...

Actavis to Buy Forest Labs (NYSE: FRX) in $25 Billion Blockbuster Deal

Last week's $45.2 billion Time Warner-Comcast deal pushed the global deal tally to $336 billion so far this year – the most since 2007 – and another blockbuster deal announced this week will push that figure even higher.

On Tuesday Irish drugmaker Actavis PLC (NYSE: ACT), producer of generic and specialty urology and women's health products, agreed to buy New York-based Forest Laboratories Inc. (NYSE: FRX) for $25 billion.

To continue reading, please click here...

Why the King IPO Tastes Bad for Investors

King IPO update: King Digital Entertainment, maker of several hit social Internet games, filed for a U.S. initial public offering (IPO) with the U.S. Securities and Exchange Commission today (Tuesday).

The stock will be listed on the New York Stock Exchange under the symbol "KING," with J.P. Morgan Chase & Co. (NYSE: JPM), Credit Suisse Group AG (NYSE: CS), and Bank of America Merrill Lynch (NYSE: BAC) leading the process.

Here's why King's IPO will be more sour than sweet...